Alzheimer's-plagued Colombia region is focus of drug trial.

Dr. John Ringman, Associate Clinical Professor of Neurology, David Geffen School of Medicine at UCLA, and Associate Clinical Director, Mary S. Easton Center for Alzheimer's Disease Research at UCLA was quoted Dec. 13 in a LA Times article about a possible therapeutic drug, which will begin the five-year clinical trial next Spring in Yarumal, Colombia. The name of this drug trial is called Alzheimer's Prevention Initiative. Dr. Ringman and his group will also be enrolling subjects in this study at the Easton Center at UCLA.